This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Hadasit Medical Research Services and Development Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2014.
Company Filing History:
1 out of 180 
1 out of 910 
Years Active: 2014
Title: Edward Sionov: Innovator in Anti-Biofilm Agents
Introduction
Edward Sionov is a notable inventor based in Azur, Illinois. He has made significant contributions to the field of biomedical research, particularly in the development of anti-biofilm agents. His innovative work focuses on creating novel agents that exhibit anti-biofilm formation activity while remaining non-cytotoxic.
Latest Patents
Sionov holds a patent for anti-biofilm agents. This patent describes methods for preventing and reducing the formation of microbial biofilms and disrupting existing biofilms. The agents include thiazolidine-2,4-diones (TZDs), pyrrolidine-2,5-diones (PYDs), imidazolidine-2,4-diones, and oxazolidine-2,4-diones, which are substituted by an alkyl chain containing 7-20 carbon atoms. This innovative approach has the potential to significantly impact medical treatments and improve patient outcomes.
Career Highlights
Throughout his career, Edward Sionov has worked with various research institutions, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Hadasit Medical Research Services and Development Ltd. His work has been instrumental in advancing the understanding and application of anti-biofilm technologies.
Collaborations
Sionov has collaborated with notable professionals in his field, including Morris Srebnik and Itzhack Polacheck. These partnerships have contributed to the development and refinement of his innovative solutions.
Conclusion
Edward Sionov's contributions to the field of anti-biofilm agents highlight his role as a significant inventor in biomedical research. His innovative approaches and collaborations continue to pave the way for advancements in this critical area.